Unique ID issued by UMIN | UMIN000033398 |
---|---|
Receipt number | R000038074 |
Scientific Title | An open-label, multi-institutional, randomized study to evaluate the additive effect of leukotriene receptor antagonist on cough score in patients with cough-variant asthma treated with inhaled corticosteroid |
Date of disclosure of the study information | 2018/07/17 |
Last modified on | 2018/07/16 10:46:43 |
An open-label, multi-institutional, randomized study to evaluate the additive effect of leukotriene receptor antagonist on cough score in patients with cough-variant asthma treated with inhaled corticosteroid
Analysis of efficacy and safety of montelucast
An open-label, multi-institutional, randomized study to evaluate the additive effect of leukotriene receptor antagonist on cough score in patients with cough-variant asthma treated with inhaled corticosteroid
Analysis of efficacy and safety of montelucast
Japan |
cough-variant asthma
Pneumology |
Others
NO
The aim of this study was to validate the additive efficacy of leukotriene receptor antagonist (LTRA) on cough score and respiratory function in patients with cough-variant asthma treated with inhaled corticosteroid (ICS).
Efficacy
cough score and peak expiratory flow (PEF)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
inhaled corticosteroids plus leukotriene receptor antagonist
inhaled corticosteroids
20 | years-old | <= |
Not applicable |
Male and Female
(1) age greater than 20; (2) dry cough continued for 3-weeks or more without wheezing; (3) cough responding to tulobuterol tapes; (4) normal respiratory function; (5) absence of rhinitis or sinusitis; (6) absence of symptom associated with gastroesophageal reflux disease; (7) not onset of respiratory infection within 3-weeks; and (8) no radiological findings
We excluded patients if they were diagnosed with bronchial asthma, atopic cough, sinobronchial syndrome, tuberculosis and lung cancer.
30
1st name | |
Middle name | |
Last name | Yoshihiro Nishimura |
Kobe University Graduate School of Medicine
Division of Respiratory Medicine, Department of Internal Medicine
7-5-1 Kusunokicho, Chuo-ku, Kobe, Hyogo 650-0017, Japan
0783825660
nishiy@med.kobe-u.ac.jp
1st name | |
Middle name | |
Last name | Tatsuya Nagano |
Kobe University Graduate School of Medicine
Division of Respiratory Medicine, Department of Internal Medicine
7-5-1 Kusunokicho, Chuo-ku, Kobe, Hyogo 650-0017, Japan
0783825660
tnagano@med.kobe-u.a.jp
Kobe University Graduate School of Medicine
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Other
NO
2018 | Year | 07 | Month | 17 | Day |
Unpublished
Completed
2007 | Year | 10 | Month | 01 | Day |
2007 | Year | 10 | Month | 01 | Day |
2018 | Year | 07 | Month | 16 | Day |
2018 | Year | 07 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038074
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |